Paul Gagnier

6.8k citations
25 papers · 1.2k indexed · 1 hit paper · h-index 13
Topics
Cancer Immunotherapy and Biomarkers (17 papers)Renal cell carcinoma treatment (7 papers)CAR-T cell therapy research (5 papers)

In The Last Decade

Paul Gagnier

25 papers receiving 1.2k citations

Hit Papers

Ipilimumab alone or in combination with radiotherapy in m...20132026201720212013100200300400

Peers

Paul Gagnier
Comparison fields: 5 of 63
  • Oncology 840
  • Pulmonary and Respiratory Medicine 504
  • Immunology 470
  • Molecular Biology 161
  • Infectious Diseases 160
Replace Moshe Chaim Ornstein with:
Moshe Chaim Ornstein United States
Flavia Zanaboni Italy
A. Lavolé France
Patrizio Mazza Italy
Erica D. Warlick United States
Anita Gustavsson Sweden
R. Williams United States
Aleksandr Lazaryan United States
Reza Gamagami United States
Jared Klein United States
Paul Gagnier relative to Moshe Chaim Ornstein United States Moshe Chaim Ornstein's profile →
Citations per field
00.5×10×16.9×
Moshe Chaim Ornstein · 1×
Citations per year

Countries citing papers authored by Paul Gagnier

Since Specialization
Citations

This map shows the geographic impact of Paul Gagnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Gagnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Gagnier more than expected).

Fields of papers citing papers by Paul Gagnier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Gagnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Gagnier. The network helps show where Paul Gagnier may publish in the future.

Co-authorship network of co-authors of Paul Gagnier

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Gagnier. A scholar is included among the top collaborators of Paul Gagnier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Gagnier. Paul Gagnier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 11
2 37
3 7
4 55
5 29
6 1
7 116
8 20
9 201
10 43
11
Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II studybreakdown →
436
12 12
13 2
14 9
15 45
16 2
17 1
18 160
19 3
20 12

About Paul Gagnier

Paul Gagnier is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Urology, having authored 25 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (17 papers), Renal cell carcinoma treatment (7 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Oncology (840 citations), Immunology (470 citations) and Virology (95 citations). Paul Gagnier has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Tomasz M. Beer, Howard I. Scher, Kevin M. Chin, Andrea Harzstark, Omid Hamid, M. Brent McHenry, Celestia S. Higano, Joshi J. Alumkal, Sheela Tejwani and Susan F. Slovin. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026